Home › NDC Lookup › Ingredients › Ammonia Inhalants › 67777-0251-01
🫁image loading
(from DailyMed)

Ammonia Inhalants .05 g/.33mL Inhalant, 33 mL — NDC 67777-251-01 (Billing 67777-0251-01)

by Dynarex Corporation · .33 mL in 1 AMPULE

This is a package of 33 mL of Ammonia Inhalants .05 g/.33mL Inhalant from Dynarex Corporation, marketed since Feb 1976 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 67777-0251-01
🏷️ FDA NDC (as labeled) 67777-251-01 billing pads the product segment with a zero
This package
Contains33 mL Pack sizes2 compare ↓
Main listing for product 67777-251 · Also comes in: 10 ampules 67777-251-02
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 67777-251-01
Product NDC 67777-251
11-digit billing NDC 67777025101
NCPDP billing unit EA — each (per item)
RxCUI 1299889
UNII 5138Q19F1X
UPC 0616784140124
SPL Set ID 91e27f1c-0f74-413e-97ff-2fc013f22ca8
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1976-02-14
Route RESPIRATORY (INHALATION)
Dosage form INHALANT
Substance AMMONIA

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 99000015102400
GPI class Ammonia Inhalants
GCN Seq No 059352
GCN 24958
HICL code 001545
Ingredient (HICL) Ammonia
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H2
Therapeutic class — intermediate (HIC2) Psychoactive Drugs
HIC3 code H2A
Therapeutic class — specific (HIC3) Central Nervous System Stimulants
AHFS code 28:20.32.00
AHFS class Respiratory And Cns Stimulants
FDB label name AMMONIA INHALANT AMPULE
FDB brand name Ammonia Inhalant
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 059352
  • GCN: 24958
  • GPI-14 (Medi-Span): 99000015102400
  • HICL (First Databank): 001545
  • AHFS class code: 28:20.32.00
  • RxCUI (RxNorm): 1299889
Why two NDCs? The FDA registers this code as 67777-251-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 67777-0251-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Radioactive Diagnostic Agent class.

Pharmacologic class Radioactive Diagnostic Agent
Drug family (ATC) Other cardiovascular system diagnostic radiopharmaceuticals
How it works Radiopharmaceutical Activity
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name AMMONIA INHALANT AMPULE Ingredient Ammonia
🧪 What is this product?

This is an over-the-counter inhalant product containing ammonia that is inhaled through the nose. Ammonia vapors are typically used to stimulate breathing and increase alertness, and have traditionally been used as a respiratory stimulant in situations where a person may feel faint or lightheaded. This product is marketed without an approved FDA application.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 10 ampules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
67777-0251-01 You're viewing this Main listing .33 mL in 1 AMPULE 1976-02-14 — Active
67777-0251-02 67777-251-02 50 BOX in 1 CASE / 10 AMPULE in 1 BOX / .33 mL in 1 AMPULE 1976-02-14 — Active

Pack size FAQ

What quantity is in this package?
This package contains 33 mL — .33 ml in 1 ampule.
What NDC number is used to bill for this package of Ammonia Inhalants .05 g/.33mL Inhalant?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
First Aid Only Ammonia Inhalants .045 g/.3mL 00924-5401-01 Acme 10 ampules — — FDA listed —
Ammonia Inhalants .045 g/.3mL 46414-3333-02 James 100 ampules — — FDA listed —
Ammonia Inhalants .05 g/.33mLthis 67777-0251-01 Dynarex 33 ml — — FDA listed —
Ammonia .15 g/g 68599-7100-01 McKesson 15 g — — Discontinued —
ammonia inhalants .045 g/.3mL 82749-0150-02 Epic 100 ampules — — FDA listed —
Allbizr Iron Shogun Smelling Salts 15 g/100g 85209-0011-01 Hong 65 g — — FDA listed —
Lepnuns SMELLING SALTS 15 g/100g 85248-0021-01 Jiangxi 40 g — — Discontinued —
WXMX Smelling Salts 15 g/100g 85248-0028-01 Jiangxi 50 g — — Discontinued —
Botasun Smelling Salts 15 g/100g 85248-0035-01 Jiangxi 40 g — — Discontinued —
Flobow SMELLING SALTS 15 g/100g 85248-0098-01 Jiangxi 40 g — — Discontinued —
Serynth Smelling Salts 15 g/100g 85248-0105-01 Jiangxi 40 g — — Discontinued —
Sylvirene Smelling Salts 15 g/100g 85248-0140-01 Jiangxi 40 g — — Discontinued —
Reinreude Smelling Salts 15 g/100g 85248-0152-01 Jiangxi 40 g — — Discontinued —
Ottffss Smelling Salts 15 g/100g 85248-0179-01 Jiangxi 40 g — — Discontinued —
Nrmrqz SMELLING SALTS 15 g/100g 85248-0182-01 Jiangxi 40 g — — Discontinued —
LukGain SMELLING SALTS 15 g/100g 85248-0186-01 Jiangxi 40 g — — Discontinued —
Rhinoost SMELLING SALTS 15 g/100g 85248-0193-01 Jiangxi 50 g — — Discontinued —
Unikinesys SMELLING SALTS 15 g/100g 85248-0197-01 Jiangxi 50 g — — Discontinued —
Hoxlbin SMELLING SALTS 15 g/100g 85248-0198-01 Jiangxi 50 g — — Discontinued —
smelling salts SMELLING SALTS 15 g/100g 85248-0225-01 Jiangxi 40 g — — Discontinued —
TideFresh SMELLING SALTS 15 g/100g 85248-0231-01 Jiangxi 40 g — — Discontinued —
Thitfam Smelling Salts 15 g/100g 85248-0234-01 Jiangxi 30 g — — Discontinued —
ANTYZE Smelling Salts 15 g/100g 85590-0001-01 Shenzhen 30 g — — FDA listed —
Gluvelop SMELLING SALTS 15 g/100g 85590-0002-01 Shenzhen 30 g — — FDA listed —
UpSniff Smelling Salts 15 g/100g 85590-0003-01 Shenzhen 30 g — — FDA listed —
TEHCIN smelling salts 15 g/100g 85593-0117-01 Guangzhou 60 g — — Discontinued —
Summit Smelling Salts 15 g/100g 85764-0001-01 Washburn 40 g — — FDA listed —
smelling salts 15 g/100g 85765-0001-01 Shenzhen 30 g — — Discontinued —
smelling salts 15 g/100g 85765-0002-01 Shenzhen 1 bottle — — Discontinued —
smelling salts .15 g/g 85765-0003-01 Shenzhen 50 g — — Discontinued —
ammonia inhalants 15 g/100mL 85813-0003-01 Direct 50 ampules — — FDA listed —
Smelling Salts 15 g/100g 85821-0001-01 Shenzhen 30 g — — FDA listed —
Smelling Salts .15 g/g 85839-0005-01 Shenzhen 30 g — — FDA listed —
Allbiz Sealed Oni Smelling Salts .15 g/g 85920-0001-01 Foshan 50 g — — Discontinued —
Allbiz Sealed Oni Smelling Salts 15 g/100g 85920-0002-01 Foshan 40 g — — Discontinued —
Allbiz Mint Oni Smelling Salts 15 g/100g 85920-0003-01 Foshan 65 g — — Discontinued —
Smelling Salt 4.5 g/30g 85999-0001-01 Nanning 30 g — — Discontinued —
Smelling Salt 15 g/100g 87055-0001-01 Guangzhou 30 g — — Discontinued —
Smelling Salt 4.5 g/30g 87175-0001-01 Guangzhou 30 g — — FDA listed —
Palinoia Ammonia Inhalant 15 g/100g 87176-0002-02 Centeroblivion 1 bottle — — Discontinued —
Smelling Salt 4.5 g/30g 87248-0001-01 Shenzhen 30 g — — FDA listed —
Snap Labs Ammonia Inhalants 150 mg/mL 87270-0001-01 Brined 1 jar — — FDA listed —
Snap Labs 20-Count Ammonia Inhalants 150 mg/mL 87270-0002-01 Brined 1 jar — — FDA listed —
Snap Labs Ammonia Inhalants 150 mg/mL 87270-0003-02 Brined 1 jar — — FDA listed —
Snap Labs Ammonia Inhalants 150 mg/mL 87270-0004-01 Brined 1 jar — — FDA listed —
Smelling Salts 15 g/100g 87585-0001-01 Guangzhou 40 g — — FDA listed —
Smelling Salts 15 g/100g 87592-0001-01 Shenzhen 30 g — — FDA listed —
Smelling Salts 15 g/100g 87711-0001-01 Hodayfa 30 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1976
On the market since
Feb 1976
📍
2026
Currently FDA-listed
50 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDynarex Corporation
Labeler code67777
First marketedFeb 1976
Product typeHuman Otc Drug
Portfolio60 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 5 words ▾

to prevent or treat fainting

⏱️ Dosage and Administration 20 words ▾

Hold inhalant away from face and crush between thumb and forefinger. carefully approach crushed inhalant to nostrils of affected person.

⚠️ Warnings 4 words ▾

for external use only

📦 Storage and Handling 7 words ▾

Store at room temperature away from light

🧪 Active Ingredient 8 words ▾

active ingredient each inhalant purpose ammonia 15% inhalant

🧪 Inactive Ingredients 14 words ▾

alcohol fdc red dye 40 lavender oil, lemon oil, nutmeg oil, purified water usp

🎯 Purpose 33 words ▾

Uses to prevent or treating fainting warnings for external use only do not use if you have breathing problems such as asthma or emphysema stop use and ask a doctor if condition persists

📄 Keep Out of Reach of Children 13 words ▾

If swallowed get medical help or contact a Poison Control Center right away

📄 Package Label / Principal Display Panel 7 words ▾

Label 1401 Ammonia Inhalants 1401 BX MASTER

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Ammonia Inhalants — the ingredient across all brands.

Top reported reactions

Seizure13
Vomiting11
Dyspnoea10
Migraine10
Diarrhoea6
Gastric Disorder6
Syncope6

Reporter sex

33 reports
Male · 55%
Female · 42%
Unknown · 3%

Serious outcomes

Disabling3
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 25 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Dynarex Corporation. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 10 ampules (67777-0251-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Dynarex Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.